A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Clinical trial NCT02174861 · COMPLETED

Trial details

NCT number: NCT02174861
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment for Prevention of Chronic Migraine

Start date: 2014-06-30
Primary completion: 2017-05-26
Enrollment: 609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.